Douglas John Meldrum Allen

Title: Douglas John Meldrum Allen: Innovator in Pharmaceutical Chemistry

Introduction

Douglas John Meldrum Allen is a notable inventor based in New London, CT (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for treating hyperproliferative disorders, including cancer. With a total of 3 patents to his name, Allen's work exemplifies the intersection of scientific research and practical application.

Latest Patents

Allen's latest patents include the following:

1. **N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate** - This invention relates to the anhydrous and hydrate forms of the compound, as well as pharmaceutical compositions containing it. The methods described aim to treat hyperproliferative disorders, such as cancer, by administering this compound.

2. **N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate** - Similar to the previous patent, this invention also focuses on the anhydrous and hydrate forms of the compound and its applications in pharmaceutical compositions for treating cancer.

Career Highlights

Throughout his career, Allen has worked with prominent companies in the pharmaceutical industry, including Osi Pharmaceuticals, Inc. and Pfizer Corporation. His experience in these organizations has allowed him to contribute to groundbreaking research and development in drug formulation and therapeutic applications.

Collaborations

Allen has collaborated with notable colleagues such as Timothy Norris and Jeffrey W. Raggon. These partnerships have fostered a collaborative environment that enhances innovation and the development of effective pharmaceutical solutions.

Conclusion

Douglas John Meldrum Allen's contributions to pharmaceutical chemistry through his patents and collaborations highlight his commitment to advancing medical science. His work continues to impact the treatment of serious health conditions, showcasing the importance of innovation in the field.